Eloctate Lyophilisate For Solution For Injection 250iu Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

ELOCTATE: Lyophilisate for solution for injection (250IU)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

ANTIHEMOPHILIC FACTOR Fc FUSION PROTEIN (an tee hee moe FIL ik fak tir Fc FYOO zhuh n PROH teen) is used in patients with Hemophilia A to help prevent and control bleeding.

In-Depth Information

ELOCTATE 250unit Powder for Injection

NDC: 644060801
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Surgical Bleeding, Bleeding Prophylaxis, Hemophilia A

Storage Information
Store in original package until time of use
May be stored at temperatures up to 86 degrees F for up to 6 months
Protect from light
Discard product if it contains particulate matter, is cloudy, or discolored
Discard unused portion. Do not store for later use.
Do not freeze
Prior to dispensing, store in refrigerator (36 to 46 degrees F)
Reconstituted product should be used within 3 hours
ELOCTATE 250unit Powder for Injection

Reported Side Effects for ELOCTATE 250unit Powder for Injection

Headache Incidence:
0.6%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
0.6%*
Severity: MODERATE
Onset: EARLY
Low Blood Pressure Incidence:
0.6%*
Severity: MODERATE
Onset: RAPID
Muscle Pain Incidence:
0.6%*
Severity: MILD
Onset: EARLY
Cough Incidence:
0.6%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
0.6%*
Severity: MILD
Onset: EARLY
Slow Heart Beat Incidence:
0.6%*
Severity: SEVERE
Onset: RAPID
Chest Pain Incidence:
0.6%*
Severity: MODERATE
Onset: EARLY
Lightheadedness Incidence:
0.6%*
Severity: MILD
Onset: EARLY
Metallic Taste Incidence:
0.6%*
Severity: MILD
Onset: EARLY
Injection Site Reaction Incidence:
0.6%*
Severity: MILD
Onset: RAPID
Skin Rash Incidence:
0.6%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
1.2%*
Severity: MILD
Onset: DELAYED
Feeling Sick Incidence:
1.2%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with ELOCTATE

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5